Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Oct. 1, 2024
Language: Английский
Mitochondrial alterations and signatures in hepatocellular carcinoma
Cancer and Metastasis Reviews,
Journal Year:
2025,
Volume and Issue:
44(1)
Published: Feb. 18, 2025
Language: Английский
Emerging roles for Mitochondrial Rho GTPases in tumor biology
Journal of Biological Chemistry,
Journal Year:
2024,
Volume and Issue:
300(9), P. 107670 - 107670
Published: Aug. 14, 2024
Language: Английский
Mitochondrial Transfer as a Strategy for Enhancing Cancer Cell Fitness:Current Insights and Future Directions
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
208, P. 107382 - 107382
Published: Aug. 30, 2024
It
is
now
recognized
that
tumors
are
not
merely
masses
of
transformed
cells
but
intricately
interconnected
with
healthy
in
the
tumor
microenvironment
(TME),
forming
complex
and
heterogeneous
structures.
Recent
studies
discovered
cancer
can
steal
mitochondria
from
to
empower
themselves,
while
reducing
functions
their
target
organ.
Mitochondrial
transfer,
i.e.
intercellular
movement
mitochondria,
recently
emerging
as
a
novel
process
biology,
contributing
growth,
metastasis,
resistance
therapy
by
shaping
metabolic
landscape
microenvironment.
This
review
highlights
influence
transferred
on
bioenergetics,
redox
balance
apoptotic
resistance,
which
collectively
foster
aggressive
phenotype.
Furthermore,
therapeutic
implications
mitochondrial
transfer
discussed,
emphasizing
potential
targeting
these
pathways
overcome
drug
improve
treatment
efficacy.
Language: Английский
Multifaceted role of HMGB1: From nuclear functions to cytoplasmic and extracellular signaling in inflammation and cancer—Review
Desislava Vladimirova,
No information about this author
Sonya Staneva,
No information about this author
Iva Ugrinova
No information about this author
et al.
Advances in protein chemistry and structural biology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 271 - 300
Published: Oct. 30, 2024
Language: Английский
Deciphering the roles of the HMGB family in cancer: Insights from subcellular localization dynamics
Junqing Jiang,
No information about this author
Mengyu Sun,
No information about this author
Yufei Wang
No information about this author
et al.
Cytokine & Growth Factor Reviews,
Journal Year:
2024,
Volume and Issue:
78, P. 85 - 104
Published: July 14, 2024
The
high-mobility
group
box
(HMGB)
family
consists
of
four
DNA-binding
proteins
that
regulate
chromatin
structure
and
function.
In
addition
to
their
intracellular
functions,
recent
studies
have
revealed
involvement
as
extracellular
damage-associated
molecular
patterns
(DAMPs),
contributing
immune
responses
tumor
development.
HMGB
promotes
tumorigenesis
by
modulating
multiple
processes
including
proliferation,
metabolic
reprogramming,
metastasis,
evasion,
drug
resistance.
Due
the
predominant
focus
on
HMGB1
in
literature,
little
is
known
about
remaining
members
this
family.
This
review
summarizes
structural,
distributional,
well
functional
similarities
distinctions
among
family,
followed
a
comprehensive
exploration
roles
We
emphasize
distributional
hierarchy
at
both
organizational
subcellular
levels,
with
relationship
microenvironment
(TIME),
aiming
prospect
potential
strategies
for
anticancer
therapy.
Language: Английский